CID 148163435

Sovilnesib

Structural Information

Molecular Formula
C26H34F2N6O4S
SMILES
CC1=CC(=NC(=N1)N2CCC(CC2)(F)F)NC(=O)C3=C(C=C(C=C3)NS(=O)(=O)CCO)N4CCC5(CC5)CC4
InChI
InChI=1S/C26H34F2N6O4S/c1-18-16-22(31-24(29-18)34-12-8-26(27,28)9-13-34)30-23(36)20-3-2-19(32-39(37,38)15-14-35)17-21(20)33-10-6-25(4-5-25)7-11-33/h2-3,16-17,32,35H,4-15H2,1H3,(H,29,30,31,36)
InChIKey
KBDGEJDIHZDPHN-UHFFFAOYSA-N
Compound name
2-(6-azaspiro[2.5]octan-6-yl)-N-[2-(4,4-difluoropiperidin-1-yl)-6-methylpyrimidin-4-yl]-4-(2-hydroxyethylsulfonylamino)benzamide
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

1
References

61
Patents

564.23303 Da
Monoisotopic Mass

3.8
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 565.24031 227.0
[M+Na]+ 587.22225 231.0
[M-H]- 563.22575 230.2
[M+NH4]+ 582.26685 223.9
[M+K]+ 603.19619 224.7
[M+H-H2O]+ 547.23029 215.8
[M+HCOO]- 609.23123 229.1
[M+CH3COO]- 623.24688 250.5
[M+Na-2H]- 585.20770 227.9
[M]+ 564.23248 223.5
[M]- 564.23358 223.5
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

patents stripe